182 related articles for article (PubMed ID: 28828379)
21. Clinical characteristics of idiopathic pulmonary fibrosis patients according to their smoking status.
Kishaba T; Nagano H; Nei Y; Yamashiro S
J Thorac Dis; 2016 Jun; 8(6):1112-20. PubMed ID: 27293827
[TBL] [Abstract][Full Text] [Related]
22. Acute exacerbations of idiopathic pulmonary fibrosis.
Antoniou KM; Wells AU
Respiration; 2013; 86(4):265-74. PubMed ID: 24157720
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Factors in the Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Retrospective Single-center Study.
Atsumi K; Saito Y; Kuse N; Kobayashi K; Tanaka T; Kashiwada T; Inomata M; Kokuho N; Hayashi H; Kamio K; Fujita K; Abe S; Azuma A; Kubota K; Gemma A
Intern Med; 2018 Mar; 57(5):655-661. PubMed ID: 29151518
[TBL] [Abstract][Full Text] [Related]
24. Tacrolimus and steroid treatment for acute exacerbation of idiopathic pulmonary fibrosis.
Horita N; Akahane M; Okada Y; Kobayashi Y; Arai T; Amano I; Takezawa T; To M; To Y
Intern Med; 2011; 50(3):189-95. PubMed ID: 21297319
[TBL] [Abstract][Full Text] [Related]
25. Effect of Acute Exacerbation of Idiopathic Pulmonary Fibrosis on Lung Transplantation Outcome.
Dotan Y; Vaidy A; Shapiro WB; Zhao H; Dass C; Toyoda Y; Marchetti N; Shenoy K; Cordova FC; Criner GJ; Mamary AJ
Chest; 2018 Oct; 154(4):818-826. PubMed ID: 29966665
[TBL] [Abstract][Full Text] [Related]
26. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
27. Acute exacerbation of idiopathic pulmonary fibrosis: a 10-year single-centre retrospective study.
Yamazoe M; Tomioka H
BMJ Open Respir Res; 2018; 5(1):e000342. PubMed ID: 30397488
[TBL] [Abstract][Full Text] [Related]
28. Acute exacerbation of idiopathic pulmonary fibrosis triggered by
Suzuki A; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Mori Y; Kondoh Y
Respir Med Case Rep; 2018; 23():103-106. PubMed ID: 29719792
[TBL] [Abstract][Full Text] [Related]
29. Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation.
Moon SW; Park MS; Kim YS; Jang J; Lee JH; Lee CT; Chung JH; Shim HS; Lee KW; Kim SS; Lee SH; Yoon HI
BMC Pulm Med; 2019 Oct; 19(1):177. PubMed ID: 31615505
[TBL] [Abstract][Full Text] [Related]
30. The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis.
Hanaka T; Kido T; Noguchi S; Yamada S; Noguchi H; Guo X; Nawata A; Wang KY; Oda K; Takaki T; Izumi H; Ishimoto H; Yatera K; Mukae H
BMC Pulm Med; 2019 Dec; 19(1):265. PubMed ID: 31888585
[TBL] [Abstract][Full Text] [Related]
31. Successful Treatment with High-dose Steroids for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Triggered by COVID-19.
Omote N; Kanemitsu Y; Inoue T; Yonezawa T; Ichihashi T; Shindo Y; Sakamoto K; Ando A; Suzuki A; Niimi A; Ito S; Imaizumi K; Hashimoto N
Intern Med; 2022 Jan; 61(2):233-236. PubMed ID: 34744107
[TBL] [Abstract][Full Text] [Related]
32. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
Tachikawa R; Tomii K; Ueda H; Nagata K; Nanjo S; Sakurai A; Otsuka K; Kaji R; Hayashi M; Katakami N; Imai Y
Respiration; 2012; 83(1):20-7. PubMed ID: 21912082
[TBL] [Abstract][Full Text] [Related]
33. Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.
Suzuki A; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Hasegawa Y
Clin Respir J; 2018 Mar; 12(3):895-903. PubMed ID: 28026113
[TBL] [Abstract][Full Text] [Related]
34. Polymyxin-B hemoperfusion for acute exacerbation of idiopathic pulmonary fibrosis: serum IL-7 as a prognostic marker.
Tachibana K; Inoue Y; Nishiyama A; Sugimoto C; Matsumuro A; Hirose M; Kitaichi M; Akira M; Arai T; Hayashi S; Inoue Y
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):113-22. PubMed ID: 22117502
[TBL] [Abstract][Full Text] [Related]
35. Azithromycin for idiopathic acute exacerbation of idiopathic pulmonary fibrosis: a retrospective single-center study.
Kawamura K; Ichikado K; Yasuda Y; Anan K; Suga M
BMC Pulm Med; 2017 Jun; 17(1):94. PubMed ID: 28629448
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis--Extended analysis of pirfenidone trial in Japan.
Kondoh Y; Taniguchi H; Ebina M; Azuma A; Ogura T; Taguchi Y; Suga M; Takahashi H; Nakata K; Sugiyama Y; Kudoh S; Nukiwa T
Respir Investig; 2015 Nov; 53(6):271-8. PubMed ID: 26521104
[TBL] [Abstract][Full Text] [Related]
37. Predictors of acute exacerbation in biopsy-proven idiopathic pulmonary fibrosis.
Kishaba T; Hozumi H; Fujisawa T; Nei Y; Enomoto N; Sugiura H; Kitani M; Suda T
Respir Investig; 2020 May; 58(3):177-184. PubMed ID: 32205147
[TBL] [Abstract][Full Text] [Related]
38. Spliceosome-associated protein 130: a novel biomarker for idiopathic pulmonary fibrosis.
Liu K; Liu D; Feng Y; Zhang H; Zeng D; Liu Q; Qu J
Ann Transl Med; 2020 Aug; 8(16):986. PubMed ID: 32953786
[TBL] [Abstract][Full Text] [Related]
39. Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm.
Ryerson CJ; Cottin V; Brown KK; Collard HR
Eur Respir J; 2015 Aug; 46(2):512-20. PubMed ID: 26232481
[TBL] [Abstract][Full Text] [Related]
40. Acute Exacerbation in Interstitial Lung Disease.
Leuschner G; Behr J
Front Med (Lausanne); 2017; 4():176. PubMed ID: 29109947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
